Morgan Stanley
PASG icon

Morgan Stanley’s Passage Bio PASG Stock Holding History

Morgan Stanley’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7K Sell
2,389
-261
-10% -$1.63K ﹤0.01% 6995
2026
Q1 		$20.8K Sell
2,650
-1,625
-38% -$16.8K ﹤0.01% 6714
2025
Q4 		$50.4K Buy
4,275
+3,937
+1,165% +$34K ﹤0.01% 6436
2025
Q3 		$2.71K Buy
338
+12
+4% +$84 ﹤0.01% 7239
2025
Q2 		$2.61K Sell
326
-15
-4% -$110 ﹤0.01% 7170
2025
Q1 		$2.41K Sell
341
-40,281
-99% -$435K ﹤0.01% 7136
2024
Q4 		$461K Buy
40,622
+39,950
+5,945% +$520K ﹤0.01% 5446
2024
Q3 		$9.41K Hold
672
– – ﹤0.01% 6733
2024
Q2 		$10.7K Sell
672
-20
-3% -$489 ﹤0.01% 6662
2024
Q1 		$18.7K Hold
692
– – ﹤0.01% 6511
2023
Q4 		$14K Sell
692
-8,154
-92% -$113K ﹤0.01% 6547
2023
Q3 		$116K Buy
8,846
+3,286
+59% +$54K ﹤0.01% 5817
2023
Q2 		$105K Sell
5,560
-7,999
-59% -$158K ﹤0.01% 5936
2023
Q1 		$260K Buy
13,559
+11,691
+626% +$317K ﹤0.01% 5585
2022
Q4 		$51.6K Sell
1,868
-23,255
-93% -$587K ﹤0.01% 6278
2022
Q3 		$629K Sell
25,123
-27,425
-52% -$1.08M ﹤0.01% 5147
2022
Q2 		$2.48M Buy
52,548
+19,377
+58% +$905K ﹤0.01% 4364
2022
Q1 		$2.06M Sell
33,171
-44,434
-57% -$3.66M ﹤0.01% 4505
2021
Q4 		$9.86M Buy
77,605
+20,433
+36% +$3.34M ﹤0.01% 2969
2021
Q3 		$11.4M Sell
57,172
-145
-0.3% -$34.6K ﹤0.01% 2744
2021
Q2 		$15.2M Buy
57,317
+27,027
+89% +$8.36M ﹤0.01% 2489
2021
Q1 		$10.6M Buy
30,290
+9,073
+43% +$3.87M ﹤0.01% 2580
2020
Q4 		$10.9M Buy
21,217
+738
+4% +$296K ﹤0.01% 2427
2020
Q3 		$5.37M Buy
20,479
+871
+4% +$300K ﹤0.01% 2658
2020
Q2 		$10.7M Buy
19,608
+4,975
+34% +$2.24M ﹤0.01% 1903
2020
Q1 		$4.61M Buy
+14,633
New +$4.58M ﹤0.01% 2535

Other funds holding PASG

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM

Morgan Stanley's PASG Position: Q2 2026 in Review

Morgan Stanley reduced its Passage Bio (PASG) stake by 9.8% in Q2 2026, selling an estimated $1.63K and leaving 2,389 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #6995.

Morgan Stanley first reported a position in PASG in Q1 2020 and has held it in 26 quarters since. The position peaked at $15.2M in Q2 2021. 30 funds tracked by Wall St. Rank hold PASG as of Q2 2026.

  • Morgan Stanley held 2,389 shares of Passage Bio worth $11.7K as of Q2 2026.
  • Morgan Stanley sold 261 Passage Bio shares in Q2 2026, an estimated $1.63K.
  • Passage Bio made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6995 holding.
  • Morgan Stanley first reported a position in Passage Bio in Q1 2020 and has held it in 26 quarters since.
  • Morgan Stanley's Passage Bio position peaked at $15.2M in Q2 2021.
  • 30 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.